US Patent Issued to Universite Paris-Saclay, Institut National de la Sante et de la Recherche Medicale (INSERM), Assistance Publique-Hopitaux de Paris on May 19 for "Method for stratifying the risk of BK virus nephropathy after a kidney transplant" (French Inventors)

ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,878, issued on May 19, was assigned to Universite Paris-Saclay (Saint Aubin, France), Institut National de la Sante et de la Recherche Medicale (INSERM) (Paris) and Assistance Publique-Hopitaux de Paris (Paris).

"Method for stratifying the risk of BK virus nephropathy after a kidney transplant" was invented by Yassine Taoufik (Paris), Antoine Durrbach (Paris) and Manon Dekeyser (Paris).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present application describes and claims a novel method for identifying and stratifying the risk of developing a BK virus nephropathy ("Nx BK-v" below) in patients having undergone a kidney transplant. This method uses ...